Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

NCT01218204 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01218204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
September 14, 2010
Completion date
June 29, 2011
Enrollment
287 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidaemias, dyslipidemias